Study of XB010 in Subjects With Solid Tumors

NCT06545331 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

396

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Solid Tumors
Esophageal Squamous Cell Cancer
Head and Neck Squamous Cell Cancer
NSCLC (Non-small Cell Lung Cancer)
Hormone-receptor-positive Breast Cancer
Triple Negative Breast Cancer (TNBC)

Interventions

DRUG: XB010
DRUG: Pembrolizumab

Sponsor

Exelixis